Chromeo™ 642 is a bright, dark-red fluorescent label that replaces Cy5*, Alexa Fluor 647*, DyLight 649* and other dyes excitable within a wavelength range of 630-650 nm. It exhibits superior luminescence properties, a broad Stokes shift, stability towards photobleaching and pH, and low cell toxicity. Chromeo 642 is compatible with various excitation sources including tungsten and xenon arc lamps, the Helium-Neon laser, the 647 line of the Argon-Krypton-Ion Laser and common red diode lasers with emissions of 635 nm or 650 nm.
Why use Chromeo™ 642?
- Photostability – enables multiple exposures and increased exposure time
- Bright fluorescence – sensitive detection
- Low background
- pH insensitive
- Easy to use – no harsh chemicals required for conjugation
- Narrow emission and absorption bands – enables multi-color experiments
Reactive fluorescent Chromeo 642 serves as a bright label for antibodies and other biomolecules, enabling detection in immunofluorescence, high content screening, ELISA and FRET applications, as well as in flow cytometry.
To ensure that you get the best possible results in your immunofluorescent staining, we recommend the use of Chromeo 642 together with our complete line of MAX Stain™ Immunofluorescence Tools, as those components have been formulated to optimize the performance of all Fluorescent Chromeo™ Dyes.
|Chromeo™ 642 Alkyne||1 unit||15192||Get Quote|
|Chromeo™ 642 Azide||1 unit||15195||Get Quote|
|Chromeo™ 642 NHS-Ester||1 unit||15199||Get Quote|
|Chromeo™ Fluorescent Dyes, Secondaries & Assays Profile|
|Cell Biology Products Brochure|
|Chromeo™ 642 Alkyne Data Sheet|
|Chromeo™ 642 Azide Data Sheet|
|Chromeo™ 642 NHS-Ester Data Sheet|
|Dye||Absorption||Emission||ε L/(mol-cm)||Stokes shift|
|Chromeo™ 642||642 nm||660 nm||180,000||18 nm|
Table 1: Properties of Chromeo™ 642.
Chromeo™ 642 is a bright, dark-red fluorescent dye that can be excited at 630-650 nm. The dye is very stable over a broad pH range and, in combination with the MAX Stain™ reagents, it shows high fluorescence intensity and photostability. Chromeo 642 and Chromeo 642 dyes are the best choice to replace dyes like Cy5, Alexa Fluor 647, DyLight 649 and their conjugates.
Figure 1: Chromeo 642 staining in HeLa cells.
We compared our Chromeo 642 antibody conjugate to other commercially available secondary antibody conjugates of the same fluorescent range, such as ATTO 647N, DyLight 649 and Alexa 647 conjugated secondary antibodies. HeLa cells were labeled with an antibody against alpha-tubulin followed by detection with the fluorescently labeled secondary antibodies. All samples were processed equally, with MAX Stain™ reagents used for all steps of the immunostaining procedure.
In the first experiment, the exposure times required for each sample to reach equal fluorescence intensity were measured. Figure 2 demonstrates that the Chromeo 642 conjugate surpasses the competition with the shortest exposure time, indicating that it has the highest fluorescence intensity.
Figure 2: Exposure times required by various dark-red emitting dyes to reach equal fluorescence.
In a second set of experiments, MAX Stain reagents were used to study the photostability of different dark-red emitting antibody-dye conjugates. Again, anti-tubulin staining was performed in HeLa cells. The cells were excited over a period of 80 seconds: images were acquired every 3.5 seconds, with an exposure time of 3 seconds for each image. Figure 3 is a plot of the fluorescence intensity of the various antibody-dye conjugates relative to the illumination time. The Chromeo 642 conjugate exhibits photostability that is comparable to that of the other conjugates tested.
Figure 3: Photobleaching analysis of various various dark-red emitting dyes in immunofluorescence experiments using MAX Stain Immunofluorescence Tools.
The brightness and photostability of Chromeo 642 conjugated secondary antibodies make them excellent tools for widefield and confocal microscopy. Because of their low background in immunofluorescence experiments, Chromeo 642 antibody conjugates are ideal partners for use with other dyes in multi-color labeling experiments. As shown in Figure 4, a Chromeo 642 antibody conjugate is used together with a Chromeo 488 antibody conjugate and DAPI to visualize the induction of Histone H2AX phosphorylation upon treatment with etoposide.
Figure 4: Multi-color staining of Phospho H2AX and tubulin using Chromeo 642 and Chromeo 488 antibodies in untreated and ETO-treated HeLa cells.
The following selected publications cite the use of and/or provide additional information about Chromeo 642:
- “Set of fluorochromophores in the wavelength range from 450 to 700 nm and suitable for labeling proteins and amino-modified DNA” by Wetzel et al (2003) Journal of Chromatography B 793:83-92.
- “A new Fluorescence Resonance Energy Transfer Pair and its Application to Oligonucleotide Labeling and Resonance Energy Transfer Hybridization Studies” by Gruber et al (2005) J. of Fluorescence 15:207-214.
- “A Resonance Energy Transfer Immunoassay Based on a Thiol-Reactive Ruthenium Donor Dye and a Longwave-Emitting Acceptor” by Weh et al (2007) ChemBioChem 8:122-128.
- “Fluorescent Silica Nanoparticles” by Maderet al (2008) Ann. N.Y. Acad. Sci. 1130:218-223.
- “Colloidal silica nanoparticles for use in click chemistry-based conjugations and florescent affinity assays” by Achatzet al (2011) Sensors and Actuators B 150:211-219.
- “Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging” by Canget al (2011) Nature 469:385-388.
The Chromeo 642 Antibody Labeling Kit has been cited in the following publications:
- “PAI-1 inhibits neutrophil efferocytosis” by Park et al (2008) PNAS 105(33):11784-11789.
- “High Mobility Group Protein-1 Inhibits Phagocytosis of Apoptotic neutrophils through Binding to Phosphatidylserine” by Liu et al (2008) J. of Immunology 181:4240-4246.
Chromeo 642 conjugated Fluorescent Secondary Antibodies have been cited in the following publications:
- “The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation” by Orsi et al (2009) FEMS yeast res. 9:301-310.
- “p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes” by Frisan et al (2010) Haematologica 95(11):1964-1968.
- “Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia” by Peppoloni et al (2011) Microbiology 157:1816-1822.